BRPI0821026A2 - Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos - Google Patents

Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos

Info

Publication number
BRPI0821026A2
BRPI0821026A2 BRPI0821026-8A BRPI0821026A BRPI0821026A2 BR PI0821026 A2 BRPI0821026 A2 BR PI0821026A2 BR PI0821026 A BRPI0821026 A BR PI0821026A BR PI0821026 A2 BRPI0821026 A2 BR PI0821026A2
Authority
BR
Brazil
Prior art keywords
minoamide
alpha
treatment
psychiatric disorders
derivatives useful
Prior art date
Application number
BRPI0821026-8A
Other languages
English (en)
Inventor
Emanuela Izzo
Laura Faravelli
Elena Barbanti
Patricia Salvati
Original Assignee
Newron Pharmaceutical S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharmaceutical S P A filed Critical Newron Pharmaceutical S P A
Publication of BRPI0821026A2 publication Critical patent/BRPI0821026A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0821026-8A 2007-12-19 2008-12-05 Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos BRPI0821026A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024584 2007-12-19
PCT/EP2008/066884 WO2009080470A1 (en) 2007-12-19 2008-12-05 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders

Publications (1)

Publication Number Publication Date
BRPI0821026A2 true BRPI0821026A2 (pt) 2015-06-16

Family

ID=39310329

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821026-8A BRPI0821026A2 (pt) 2007-12-19 2008-12-05 Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos

Country Status (15)

Country Link
US (1) US8445539B2 (pt)
EP (1) EP2222290B1 (pt)
JP (1) JP5736175B2 (pt)
KR (1) KR101500962B1 (pt)
CN (1) CN101903021B (pt)
AR (1) AR071278A1 (pt)
AU (1) AU2008340552B2 (pt)
BR (1) BRPI0821026A2 (pt)
CA (1) CA2707646C (pt)
EA (1) EA019529B1 (pt)
ES (1) ES2878063T3 (pt)
IL (1) IL206107A (pt)
NZ (1) NZ586182A (pt)
TW (1) TWI441631B (pt)
WO (1) WO2009080470A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ545502A (en) * 2003-08-25 2010-04-30 Newron Pharm Spa Alpha-aminoamide derivatives useful as anti-inflammatory agents
CN101472880B (zh) 2006-06-19 2013-04-24 纽朗制药有限公司 生产2-[4-(3-和2-氟苄氧基)苄氨基]丙酰胺类的方法
BR112012027623B1 (pt) 2010-04-27 2021-07-06 Newron Pharmaceuticals S.P.A. Processo para a produção de sais de ralfinamida metanossulfonato ou seus renantiômeros, forma pseudopolimorfa de hemi-hidrato cristalino h do sal de metanossulfonato de ralfinamida, ou seu r-enantiômero, seu uso e formulação farmacêutica que o compreende
CA2986083A1 (en) 2015-06-11 2016-12-15 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
US10407315B2 (en) * 2016-04-14 2019-09-10 Seoul Semiconductor Co., Ltd. Method and/or system for synthesis of zinc oxide (ZnO)
US11225460B2 (en) 2018-03-08 2022-01-18 Sunshine Lake Pharma Co., Ltd. Pyrrolidineamide derivatives and uses thereof
CN112704678B (zh) * 2020-12-02 2024-02-23 江苏恩华药业股份有限公司 一种丙酰胺衍生物在制备治疗精神分裂症药物中应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
DE69842004D1 (de) 1997-11-21 2010-12-30 Purdue Neuroscience Co Substituierte 2-aminoacetamide und anwendung davon
AR044007A1 (es) * 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1533295A1 (en) * 2003-11-24 2005-05-25 Newron Pharmaceuticals S.p.A. Cyclopentyl Derivatives
EP1588704A1 (en) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
JP5319920B2 (ja) * 2004-09-10 2013-10-16 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
JP5271087B2 (ja) 2005-12-22 2013-08-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー カルシウム及び／又はナトリウムチャネル調節物質としての２−フェニルエチルアミノ誘導体
EP1870097A1 (en) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders

Also Published As

Publication number Publication date
ES2878063T3 (es) 2021-11-18
EP2222290B1 (en) 2021-06-16
KR101500962B1 (ko) 2015-03-10
WO2009080470A1 (en) 2009-07-02
KR20100102670A (ko) 2010-09-24
EP2222290A1 (en) 2010-09-01
NZ586182A (en) 2012-02-24
AU2008340552A1 (en) 2009-07-02
IL206107A (en) 2013-10-31
CN101903021B (zh) 2012-11-14
AR071278A1 (es) 2010-06-09
TW200934478A (en) 2009-08-16
TWI441631B (zh) 2014-06-21
US8445539B2 (en) 2013-05-21
JP5736175B2 (ja) 2015-06-17
US20110014304A1 (en) 2011-01-20
CA2707646C (en) 2016-09-13
CN101903021A (zh) 2010-12-01
IL206107A0 (en) 2010-11-30
AU2008340552A2 (en) 2010-07-29
EA201070753A1 (ru) 2010-12-30
AU2008340552B2 (en) 2013-08-22
EA019529B1 (ru) 2014-04-30
JP2011506518A (ja) 2011-03-03
HK1146221A1 (en) 2011-05-20
CA2707646A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
PL1951030T3 (pl) Udoskonalone sposoby i środki do wytwarzania hialuronianu
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
PL2049132T3 (pl) Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
SI3424932T1 (sl) Boronoftalidi za terapevtsko uporabo
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
ZA201005116B (en) 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
DK2173831T3 (da) Brøndbehandling
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
ITMI20071915A1 (it) Derivati dell'artemisinina per il trattamento del melanoma
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
BRPI0714307A2 (pt) Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos
ZA201003115B (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
FI20085752A0 (fi) Säädettävä hierontalaite ja menetelmä hierontalaitteen säätämiseksi
GB0725077D0 (en) Antifolate com[ounds for the treatment of melanoma
DK1940447T3 (da) Behandling af neurodegenrative lidelser
SE0501685L (sv) Justerbara hjul
HK1148208A (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
BRPI0716580A2 (pt) Tratamento de distúrbios fibrosantes

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: NEWRON PHARMACEUTICAL S.P.A. (IT)